|
|
||||||||
Ann Thorac Surg 2002;73:900-904
© 2002 The Society of Thoracic Surgeons
a Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
b Department of Thoracic Surgery, Kanazawa Medical University, Uchinada, Ishikawa, Japan
c Department of Surgery, Sendai Kosei Hospital, Sendai, Japan
Accepted for publication October 16, 2001.
* Address reprint requests to Dr Sagawa, Department of Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan
e-mail: sagawam{at}kanazawa-med.ac.jp
| Abstract |
|---|
|
|
|---|
Methods. Patients with clinical stage I lung cancer were the candidates for this study. Thoracotomy was performed with a small skin incision of 7 cm to 8 cm in length. Through these small wounds and two trocars, pulmonary resection was performed and then hilar and mediastinal lymph nodes were dissected. After that, a standard thoracotomy was carried out by another surgeon to complete systematic nodal dissection.
Results. Video-assisted thoracic surgery lobectomy with lymph node dissection was accomplished in 17 right lung cancer patients and 12 left lung cancer patients. On the right side, the average numbers of resected lymph nodes by VATS and remnant lymph nodes were 40.3 and 1.2, respectively. The average weights of dissected tissues by VATS and remnant tissues were 10.0 g and 0.2 g, respectively. On the left side, there were 37.1 and 1.2 lymph nodes and 8.3 g and 0.2 g of weight of dissected tissues. No nodal involvement was observed in the remnant lymph nodes.
Conclusions. The lymph node dissection with VATS was technically feasible and the remnant ("missed" by VATS) lymph nodes and tissues were 2% to 3%, which seems acceptable for clinical stage I lung cancer.
| Introduction |
|---|
|
|
|---|
There have been no reports evaluating the completeness of systematic nodal dissection [10] with VATS except our preliminary report with 6 right lung cancer patients [11]. To elucidate the completeness of the dissection and also to evaluate the actual remnant ratio of lymph nodes and tissues, we have conducted a prospective trial with patients having primary lung cancer.
| Patients and methods |
|---|
|
|
|---|
The TNM classification was determined according to the Union Internationale Contre le Cancer (UICC) staging system [12]. Histologic typing was classified according to World Health Organization (WHO) classification [13]. Lymph nodes were numbered (1 through 13) according to lymph node mapping reported by Naruke and associates [14] and the American Thoracic Society [15].
Thoracotomy was performed with a small skin incision of 7 cm to 8 cm in length at the fifth intercostal space just below the lower angle of scapular bone for right lung cancer. Respiratory muscles and ribs were not severed except intercostal muscles. Two more trocars were placed at the fourth intercostal spaces at the anterior axillary line and the seventh or eighth intercostal spaces at the mid axillary line. For left lung cancer, the skin incision of cases 1 to 8 was the same as right lung cancer. However, the skin incision of cases 9 to 12 was changed to the fourth intercostal spaces at the anterior axillary line. The trocars were also changed to the seventh or eighth intercostal spaces at the mid axillary line and the sixth intercostal spaces at the posterior axillary line. The retractor was routinely utilized. Through these small wounds and two trocars, the designated pulmonary lobe was resected and then hilar and mediastinal lymph node dissection was performed (VATS lobectomy with lymph node dissection). The pulmonary vein and bronchus were transected with staplers and branches of the pulmonary artery were ligated and transected through the small thoracotomy wound in most cases. Usually the operation was performed approximately 50% under direct vision and 50% under videoscope.
After VATS lobectomy with lymph node dissection, a standard thoracotomy was subsequently carried out by a different surgeon to complete systematic nodal dissection. The standard thoracotomy in our institute was posterolateral thoracotomy with an approximately 15 cm skin incision at the fifth intercostal space, severing the broadest muscle of the back and the fifth or sixth rib or both. Nodal dissection was performed by dissecting soft tissues surrounding vital structures. During the VATS lobectomy, when going on with the procedure became difficult owing to possible bleeding or adhesion, conversion to the standard thoracotomy was performed.
At VATS lobectomy with lymph node dissection, the number of dissected lymph nodes and the weight of dissected tissues including fat tissue at each station were measured and recorded. In addition, the number of remnant ("missed" by VATS) lymph nodes and the weight of remnant tissues of each station, found at additional thoracotomy, were measured and recorded as well. Remnant ratio was calculated both in number and in weight. Operating time required for VATS lobectomy with lymph node dissection and the amount of bleeding during the procedure were also recorded.
| Results |
|---|
|
|
|---|
|
The results of VATS lobectomy with lymph node dissection and the subsequent thoracotomy are shown in Table 2 (right side) and Table 3 (left side).
|
|
In the left side the average number of resected lymph nodes by VATS was 37.1 and the number of remnant lymph nodes ranged from 0 to 4 (average 1.2). The remnant lymph nodes were 0% to 8.7% (average 2.4%) of those that should be dissected. The weight of dissected tissues by VATS was from 4.3 g to 19.4 g (average 8.3 g) and the weight of remnant tissues ranged from 0 g to 0.5 g (average 0.2 g). The remnant tissues were 0% to 5.6% (average 1.7%) of those that should be dissected. The stations at which the remnant lymph nodes were found were 3 (2 cases), 3a, 6 (2 cases), 7, 8, 9, and 10. Of them, 3, 6, and 7 were 6 mm or larger.
Lymph node metastases were confirmed pathologically in 9 of 29 patients: case 1 (lymph node number 3), case 3 (1, 3, 12u, 12m, 13), case 6 (4), case 13 (7, 10, 11), case 15 (3, 4), case 18 (11), case 19 (11), case 22 (4, 10, 11, 12u), and case 23 (12u). Nodal involvement was not detected in the remnant lymph nodes even in pN1 and pN2 patients.
| Comment |
|---|
|
|
|---|
Most of the remnant nodes were very small and located at the edge of dissected area, such as lymph node 1 (highest mediastinal node), 3a (anterior mediastinal node adjacent to thymus), 3p (retrotracheal node adjacent to contralateral 3p), 7 (subcarinal node adjacent to contralateral hilar node), 8 (paraesophageal node adjacent to contralateral 8), 9 (pulmonary ligament node adjacent to diaphragm), or 3 for left side (pretracheal, deepest in the aortic arch). We consider that these small remnant nodes located at the edge of dissected area have less clinical importance, especially in clinical stage I cases. Actually no nodal involvement was observed in the remnant lymph nodes in this study, although preoperative evaluation of lymph node metastasis failed in 9 of 29 (31%) cases.
It is important that part of hilar nodes failed to be dissected in 3 cases (cases 1, 12, and 18). Two of them were the cases in the beginning of this study. In the dissection by VATS the surgical view was more limited than in the standard thoracotomy, in our experience, especially in the hilar region because the effective traction of residual lung or the appropriate change of the operators view angle (including thoracoscopic) is sometimes difficult. Careful attention must be paid not to overlook the remnant lymph nodes in the hilar region. In addition, the right number 4 node (tracheobronchial node) is also important and should be dissected with appropriate traction of the azygos vein.
There are some methodologic problems to be discussed. First, at the beginning of this study we encouraged patients with clinical T1N0M0 disease to enter the study because such patients were expected to undergo VATS lobectomy with lymph node dissection easily. Later we found this procedure was able to be applied to selected (peripheral and not so large) clinical T2N0M0 patients safely. Therefore, most of the patients in this study were T1N0M0 and the results of the present study might not be applied to the patients with large T2N0M0 lung cancers.
Second, our results show that the remnant nodes and tissues were only 2% to 3% of those that should be dissected, with a 7 to 8 cm skin incision and a retractor. Although VATS lobectomy with a smaller incision or without a retractor may have the advantages of less invasiveness and less pain, the remnant nodes in such conditions would be possibly different from our study. To resolve the problem, further study is required.
Third, in order to perform VATS lobectomy several approaches have been reported [2, 8, 9, 16, 17]. Although the axillary approach is useful in dissecting hilar structures [8, 9], the posterior approach seems to be suitable for mediastinal lymph node dissection [16], especially for dissecting subcarinal nodes. Therefore in the beginning of this study we chose the posterior approach for a small thoracotomy. From our experiences with the right side, the subcarinal, pretracheal, and highest mediastinal nodes were found to be easily dissected and no problem was observed in conducting this procedure through the posterior approach. In the left side, however, the descending aorta sometimes obstructs the surgical view. Therefore we switched to the axillar approach for left lung cancer, and had no problems in doing so.
In conclusion, the lymph node dissection with VATS was technically feasible, and the remnant (missed by VATS) lymph nodes and tissues were 2% to 3%, which seems acceptable for clinical stage I lung cancer. With informed consent from each patient concerning this slightly less curative potential, VATS lobectomy with lymph node dissection can be an alternate for surgical therapy of clinical stage I lung cancer patients. Prospective randomized trials will be required to evaluate the actual significance of this procedure.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
S. Sawada, E. Komori, and M. Yamashita Evaluation of video-assisted thoracoscopic surgery lobectomy requiring emergency conversion to thoracotomy Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 487 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Loscertales, R. Jimenez-Merchan, M. Congregado, F. J. Ayarra, G. Gallardo, and A. Trivino Video-Assisted Surgery for Lung Cancer. State of the Art and Personal Experience Asian Cardiovasc Thorac Ann, June 1, 2009; 17(3): 313 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim and C. H. Kang The Future of Thoracoscopic Lobectomy in Lung Cancer Asian Cardiovasc Thorac Ann, April 1, 2009; 17(2): 131 - 132. [Full Text] [PDF] |
||||
![]() |
B. Witte, A. Messerschmidt, H. Hillebrand, S. Gross, M. Wolf, E. Kriegel, W. Neumeister, and M. Hurtgen Combined videothoracoscopic and videomediastinoscopic approach improves radicality of minimally invasive mediastinal lymphadenectomy for early stage lung carcinoma Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nicastri, J. P. Wisnivesky, V. R. Litle, J. Yun, C. Chin, F. R. Dembitzer, and S. J. Swanson Thoracoscopic lobectomy: Report on safety, discharge independence, pain, and chemotherapy tolerance J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 642 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Flores and N. Alam Video-Assisted Thoracic Surgery Lobectomy (VATS), Open Thoracotomy, and the Robot for Lung Cancer Ann. Thorac. Surg., February 1, 2008; 85(2): S710 - S715. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Demmy and C. Nwogu Is Video-Assisted Thoracic Surgery Lobectomy Better? Quality of Life Considerations Ann. Thorac. Surg., February 1, 2008; 85(2): S719 - S728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Swanson, J. E. Herndon II, T. A. D'Amico, T. L. Demmy, R. J. McKenna Jr, M. R. Green, and D. J. Sugarbaker Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802 A Prospective, Multi-Institution Feasibility Study J. Clin. Oncol., November 1, 2007; 25(31): 4993 - 4997. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Nwogu, M. Glinianski, and T. L. Demmy Minimally invasive pneumonectomy. Ann. Thorac. Surg., July 1, 2006; 82(1): e3 - e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakano, K. Miyauchi, A. Horiuchi, and K. Kawachi Combined mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy Interactive CardioVascular and Thoracic Surgery, August 1, 2005; 4(4): 374 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Watanabe, T. Koyanagi, T. Obama, H. Ohsawa, T. Mawatari, N. Takahashi, Y. Ichimiya, and T. Abe Assessment of node dissection for clinical stage I primary lung cancer by VATS Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 745 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sagawa, M. Sugita, Y. Takeda, H. Toga, and T. Sakuma Video-Assisted Bronchial Stump Reinforcement With an Intercostal Muscle Flap Ann. Thorac. Surg., December 1, 2004; 78(6): 2165 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohtsuka, H. Nomori, H. Horio, T. Naruke, and K. Suemasu Is Major Pulmonary Resection by Video-Assisted Thoracic Surgery an Adequate Procedure in Clinical Stage I Lung Cancer? Chest, May 1, 2004; 125(5): 1742 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, Y. Minamiya, Y. Katayose, H. Saito, K. Taguchi, H. Imano, H. Watanabe, K. Enomoto, M. Sageshima, T. Ueda, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 563 - 567. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |